Metabonomic variations associated with AOM-induced precancerous colorectal lesions and resveratrol treatment

Journal of Proteome Research

Volumn 11, Issue 6, 2012, Pages 3436-3448

  Liao, Wen ^a   Wei, Hai ^a   Wang, Xiaoyan ^c   Qiu, Yunping ^b   Gou, Xiaojun ^a   Zhang, Xiaolei ^a   Zhou, Mingmei ^a   Wu, Jianbing ^a   Wu, Tao ^a   Kou, Fang ^a   Zhang, Yongyu ^a   Bian, Zhaoxiang ^d   Xie, Guoxiang ^b   Jia, Wei ^a,b  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

^c Shanghai Jiao Tong University   (China)

^d HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

AOM; azoxymethane; colorectal cancer; gas chromatography time of flight mass spectrometry; GC TOFMS; metabonomics; resveratrol

Indexed keywords

2 AMINOBUTYRIC ACID; 3 HYDROXYBUTYRIC ACID; 4 AMINOBUTYRIC ACID; 4 HYDROXYPHENYLACETIC ACID; AMINOOXYACETIC ACID; ARACHIDONIC ACID; AZOXYMETHANE; CHOLESTEROL; CYSTINE; DOCOSAHEXAENOIC ACID; GLUCOSE; GLUTAMIC ACID; GLYCEROPHOSPHATE; HIGH DENSITY LIPOPROTEIN; HYDROXYPROLINE; HYPOXANTHINE; ISOLEUCINE; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN; MANNOSE; ORNITHINE; PANTOTHENIC ACID; PHENYLALANINE; PYROGLUTAMIC ACID; RESVERATROL; TRIACYLGLYCEROL; TRYPTOPHAN; TYROSINE; VALINE; XANTHURENIC ACID; ANTINEOPLASTIC AGENT; STILBENE DERIVATIVE;

ABERRANT CRYPT FOCUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ATTENUATION; CARCINOGENESIS; CHEMOPROPHYLAXIS; CHOLESTEROL BLOOD LEVEL; COLON; COLORECTAL TUMOR; CONTROLLED STUDY; DIET THERAPY; GAS CHROMATOGRAPHY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HISTOPATHOLOGY; INFLAMMATION; LIPID BLOOD LEVEL; LIPID METABOLISM; MALE; METABOLISM; NONHUMAN; OXIDATION; PRECANCER; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; SERUM; TIME OF FLIGHT MASS SPECTROMETRY; TRIACYLGLYCEROL BLOOD LEVEL; URINE; ANIMAL; BLOOD; CHEMICALLY INDUCED; COLORECTAL NEOPLASMS; COMPARATIVE STUDY; METABOLOME; PRECANCEROUS CONDITIONS; WISTAR RAT;

RATTUS; RATTUS NORVEGICUS; VITACEAE;

ANIMALS; ANTICARCINOGENIC AGENTS; AZOXYMETHANE; COLORECTAL NEOPLASMS; MALE; METABOLOME; PRECANCEROUS CONDITIONS; RATS; RATS, WISTAR; STILBENES;

EID: 84861833964     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr300284h     Document Type: Article

References (54)

1. American Cancer Society, Colorectal Cancer Facts & Figures 2011-2013.
2. Park, S. Y.; Kim, J. S.; Seo, Y. R.; Sung, M. K. Effects of diet-induced obesity on colitis-associated colon tumor formation in A/J mice Int. J. Obes. 2012, 36, 273-80
3. Qiu, Y.; Cai, G.; Su, M.; Chen, T.; Liu, Y.; Xu, Y.; Ni, Y.; Zhao, A.; Cai, S.; Xu, L. X.; Jia, W. Urinary metabonomic study on colorectal cancer J. Proteome Res. 2010, 9 (3) 1627-34
4. Sung, J. J.; Lau, J. Y.; Goh, K. L.; Leung, W. K. Increasing incidence of colorectal cancer in Asia: implications for screening Lancet Oncol. 2005, 6 (11) 871-6
5. Norlida, A. O.; Phang, K. S. Histomorphology of aberrant crypt foci in colorectal carcinoma Malays. J. Pathol. 2010, 32 (2) 111-6
6. Colorectal Canver, American Cancer Society Home Page. http://www.cancer.org/Cancer/ColonandRectumCancer/DetailedGuide/ colorectal-cancer-staged.
7. Alfaras, I.; Juan, M. E.; Planas, J. M. trans -Resveratrol reduces precancerous colonic lesions in dimethylhydrazine-treated rats J. Agric. Food Chem. 2010, 58 (13) 8104-10
8. Lin, H.-Y.; Landersdorfer, C. B.; London, D.; Meng, R.; Lim, C.-U.; Lin, C.; Lin, S.; Tang, H.-Y.; Brown, D.; Van Scoy, B.; Kulawy, R.; Queimado, L.; Drusano, G. L.; Louie, A.; Davis, F. B.; Mousa, S. A.; Davis, P. J. Pharmacodynamic modeling of anti-cancer activity of tetraiodothyroacetic acid in a perfused cell culture system PLoS Comput. Biol. 2011, 7 (2 e1001073
9. Paul, B.; Masih, I.; Deopujari, J.; Charpentier, C. Occurrence of resveratrol and pterostilbene in age-old darakchasava, an ayurvedic medicine from India J. Ethnopharmacol. 1999, 68 (1-3) 71-6
10. Cui, X.; Jin, Y.; Hofseth, A. B.; Pena, E.; Habiger, J.; Chumanevich, A.; Poudyal, D.; Nagarkatti, M.; Nagarkatti, P. S.; Singh, U. P.; Hofseth, L. J. Resveratrol suppresses colitis and colon cancer associated with colitis Cancer Prev. Res. 2010, 3 (4) 549-59
11. Larrosa, M.; Yanez-Gascon, M. J.; Selma, M. V.; Gonzalez-Sarrias, A.; Toti, S.; Ceron, J. J.; Tomas-Barberan, F.; Dolara, P.; Espin, J. C. Effect of a low dose of dietary resveratrol on colon microbiota, inflammation and tissue damage in a DSS-induced colitis rat model J. Agric. Food Chem. 2009, 57 (6) 2211-20
12. Jang, M. S.; Cai, E. N.; Udeani, G. O.; Slowing, K. V.; Thomas, C. F.; Beecher, C. W. W.; Fong, H. H. S.; Farnsworth, N. R.; Kinghorn, A. D.; Mehta, R. G.; Moon, R. C.; Pezzuto, J. M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes Science 1997, 275 (5297) 218-220
13. Yusuf, N.; Nasti, T. H.; Meleth, S.; Elmets, C. A. Resveratrol enhances cell-mediated immune response to DMBA through TLR4 and prevents DMBA induced cutaneous carcinogenesis Mol. Carcinog. 2009, 48 (8) 713-23
14. Zykova, T. A.; Zhu, F.; Zhai, X.; Ma, W. Y.; Ermakova, S. P.; Lee, K. W.; Bode, A. M.; Dong, Z. Resveratrol directly targets COX-2 to inhibit carcinogenesis Mol. Carcinog. 2008, 47 (10) 797-805
15. Vanamala, J.; Reddivari, L.; Radhakrishnan, S.; Tarver, C. Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways BMC Cancer 2010, 10, 238
16. Chan, E. C.; Koh, P. K.; Mal, M.; Cheah, P. Y.; Eu, K. W.; Backshall, A.; Cavill, R.; Nicholson, J. K.; Keun, H. C. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS) J. Proteome Res. 2009, 8 (1) 352-61
17. Qiu, Y.; Cai, G.; Su, M.; Chen, T.; Zheng, X.; Xu, Y.; Ni, Y.; Zhao, A.; Xu, L. X.; Cai, S.; Jia, W. Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS J. Proteome Res. 2009, 8 (10) 4844-50
18. Shamsuddin, A. M. Comparative studies of primary, metastatic and transplanted colon adenocarcinomas of Fischer 344 rats J. Submicrosc. Cytol. 1984, 16 (2) 327-39
19. Femia, A. P.; Caderni, G. Rodent models of colon carcinogenesis for the study of chemopreventive activity of natural products Planta Med. 2008, 74 (13) 1602-7
20. Suh, N.; Paul, S.; Hao, X.; Simi, B.; Xiao, H.; Rimando, A. M.; Reddy, B. S. Pterostilbene, an active constituent of blueberries, suppresses aberrant crypt foci formation in the azoxymethane-induced colon carcinogenesis model in rats Clin. Cancer Res. 2007, 13 (1) 350-5
21. Morotomi, M.; Sakaitani, Y.; Satou, M.; Takahashi, T.; Takagi, A.; Onoue, M. Effects of a high-fat diet on azoxymethane-induced aberrant crypt foci and fecal biochemistry and microbial activity in rats Nutr. Cancer 1997, 27 (1) 84-91
22. Pan, L.; Qiu, Y. P.; Chen, T. L.; Lin, J. C.; Chi, Y.; Su, M. M.; Zhao, A. H.; Jia, W. An optimized procedure for metabonomic analysis of rat liver tissue using gas chromatography/time-of-flight mass spectrometry J. Pharm. Biomed. Anal. 2010, 52 (4) 589-96
23. Qi, Y.; Li, P.; Zhang, Y. Y.; Cui, L. L.; Guo, Z.; Xie, G. X.; Su, M. M.; Li, X.; Zheng, X. J.; Qiu, Y. P.; Liu, Y. M.; Zhao, A. H.; Jia, W. P.; Jia, W. Urinary metabolite markers of precocious puberty Mol. Cell. Proteomics 2012, 11 (1 M111.011072
24. Pike, N. Using false discovery rates for multiple comparisons in ecology and evolution Methods Ecol. Evol. 2011, 2 (3) 278-82
25. Seyfried, B. T.; Kiebish, M.; Marsh, J.; Mukherjee, P. Targeting energy metabolism in brain cancer through calorie restriction and the ketogenic diet J. Cancer Res. Ther. 2009, 5 (Suppl. 1) S7-15
26. Warburg, O. On the origin of cancer cells Science 1956, 123 (3191) 309-14
27. Cai, Z.; Zhao, J. S.; Li, J. J.; Peng, D. N.; Wang, X. Y.; Chen, T. L.; Qiu, Y. P.; Chen, P. P.; Li, W. J.; Xu, L. Y.; Li, E. M.; Tam, J. P.; Qi, R. Z.; Jia, W.; Xie, D. A combined proteomics and metabolomics profiling of gastric cardia cancer reveals characteristic dysregulations in glucose metabolism Mol. Cell. Proteomics 2010, 9 (12) 2617-28
28. Herrmann, K.; Walch, A.; Balluff, B.; Tanzer, M.; Hofler, H.; Krause, B. J.; Schwaiger, M.; Friess, H.; Schmid, R. M.; Ebert, M. P. Proteomic and metabolic prediction of response to therapy in gastrointestinal cancers Nat. Clin. Pract. Gastroenterol. Hepatol. 2009, 6 (3) 170-83
29. Wei, J.; Xie, G. X.; Ge, S. Y.; Qiu, Y. P.; Liu, W.; Lu, A. P.; Chen, T. L.; Li, H. K.; Zhou, Z. T.; Jia, W. Metabolic transformation of DMBA-induced carcinogenesis and inhibitory effect of salvianolic acid B and breviscapine treatment J. Proteome Res. 2012, 11 (2) 1302-16
30. Bird, R. P.; Good, C. K. The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer Toxicol. Lett. 2000, 112-113, 395-402
31. McLellan, E.; Bird, R. P. Effect of disulfiram on 1,2-dimethylhydrazine- and azoxymethane-induced aberrant crypt foci Carcinogenesis 1991, 12 (6) 969-72
32. Bird, R. P. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer Cancer Lett. 1995, 93 (1) 55-71
33. Xiao, H.; Hao, X.; Simi, B.; Ju, J.; Jiang, H.; Reddy, B. S.; Yang, C. S. Green tea polyphenols inhibit colorectal aberrant crypt foci (ACF) formation and prevent oncogenic changes in dysplastic ACF in azoxymethane-treated F344 rats Carcinogenesis 2008, 29 (1) 113-9
34. Rao, C. V.; Simi, B.; Reddy, B. S. Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon Carcinogenesis 1993, 14 (11) 2219-25
35. Kim, D. J.; Shin, D. H.; Ahn, B.; Kang, J. S.; Nam, K. T.; Park, C. B.; Kim, C. K.; Hong, J. T.; Kim, Y. B.; Yun, Y. W.; Jang, D. D.; Yang, K. H. Chemoprevention of colon cancer by Korean food plant components Mutat. Res., Fundam. Mol. Mech. Mutagen. 2003, 523, 99-107
36. Song, J.; Medline, A.; Mason, J. B.; Gallinger, S.; Kim, Y. I. Effects of dietary folate on intestinal tumorigenesis in the apcMin mouse Cancer Res. 2000, 60 (19) 5434-40
37. Harris, G. K.; Gupta, A.; Nines, R. G.; Kresty, L. A.; Habib, S. G.; Frankel, W. L.; LaPerle, K.; Gallaher, D. D.; Schwartz, S. J.; Stoner, G. D. Effects of lyophilized black raspberries on azoxymethane-induced colon cancer and 8-hydroxy-2′-deoxyguanosine levels in the Fischer 344 rat Nutr. Cancer 2001, 40 (2) 125-33
38. Miyamoto, S.; Tanaka, T.; Murakami, A. Increased visceral fat mass and insulin signaling in colitis-related colon carcinogenesis model mice Chem.-Biol. Interact. 2010, 183 (2) 271-5
39. Cowey, S. L.; Quast, M.; Belalcazar, L. M.; Wei, J.; Deng, X.; Given, R.; Singh, P. Abdominal obesity, insulin resistance, and colon carcinogenesis are increased in mutant mice lacking gastrin gene expression Cancer 2005, 103 (12) 2643-53
40. Wang, Y. Y.; Lin, S. Y.; Lai, W. A.; Liu, P. H.; Sheu, W. H. Association between adenomas of rectosigmoid colon and metabolic syndrome features in a Chinese population J. Gastroenterol. Hepatol. 2005, 20 (9) 1410-5
41. Tomiki, Y.; Suda, S.; Tanaka, M.; Okuzawa, A.; Matsuda, M.; Ishibiki, Y.; Sakamoto, K.; Kamano, T.; Tsurumaru, M.; Watanabe, Y. Reduced low-density-lipoprotein cholesterol causing low serum cholesterol levels in gastrointestinal cancer: a case control study J. Exp. Clin. Cancer Res. 2004, 23 (2) 233-40
42. Tsilidis, K. K.; Brancati, F. L.; Pollak, M. N.; Rifai, N.; Clipp, S. L.; Hoffman-Bolton, J.; Helzlsouer, K. J.; Platz, E. A. Metabolic syndrome components and colorectal adenoma in the CLUE II cohort Cancer Causes Control 2010, 21 (1) 1-10
43. Kang, B. S.; Ahn, D. H.; Kim, N. K.; Kim, J. W. Relationship between metabolic syndrome and MTHFR polymorphism in colorectal cancer J. Korean Soc. Coloproctol. 2011, 27 (2) 78-82
44. Das, S.; Das, D. K. Anti-inflammatory responses of resveratrol Inflammation Allergy: Drug Targets 2007, 6 (3) 168-73
45. Andres Rubiolo, J.; Mithieux, G.; Victor Vega, F. Resveratrol protects primary rat hepatocytes against oxidative stress damage: Activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes Eur. J. Pharmacol. 2008, 591 (1-3) 66-72
46. Seyfried, T. N.; Shelton, L. M. Cancer as a metabolic disease Nutr. Metab. 2010, 7
47. Brown, G. K.; Cromby, C. H.; Manning, N. J.; Pollitt, R. J. Urinary organic acids in succinic semialdehyde dehydrogenase deficiency: evidence of alpha-oxidation of 4-hydroxybutyric acid, interaction of succinic semialdehyde with pyruvate dehydrogenase and possible secondary inhibition of mitochondrial beta-oxidation J. Inherit. Metab. Dis. 1987, 10 (4) 367-75
48. Chang, C.; Jang, T. Age-dependent neurotoxicity of striatal lesions produced by aminooxyacetic acid: quantitative in vitro 1H NMR spectroscopic studies J. Neurochem. 1995, 65 (3) 1192-8
49. Jeoung, N. H.; Harris, R. A. Pyruvate dehydrogenase kinase-4 deficiency lowers blood glucose and improves glucose tolerance in diet-induced obese mice Am. J. Physiol.: Endocrinol. Metab. 2008, 295 (1) E46-54
50. Wierzbicki, A. S.; Mayne, P. D.; Lloyd, M. D.; Burston, D.; Mei, G.; Sidey, M. C.; Feher, M. D.; Gibberd, F. B. Metabolism of phytanic acid and 3-methyl-adipic acid excretion in patients with adult Refsum disease J. Lipid Res. 2003, 44 (8) 1481-8
51. Gatenby, R. A.; Gillies, R. J. Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 2004, 4 (11) 891-9
52. Laeger, T.; Metges, C. C.; Kuhla, B. Role of beta-hydroxybutyric acid in the central regulation of energy balance Appetite 2010, 54 (3) 450-5
53. Nowak, A.; Libudzisz, Z. Influence of phenol, p-cresol and indole on growth and survival of intestinal lactic acid bacteria Anaerobe 2006, 12 (2) 80-4
54. Human Metabolome Database Home Page. www.hmdb.ca.